{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-021666","form_type":"8-K","ticker":null,"cik":"0001782754","company_name":"AZEK Co Inc.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.075313+00:00","generated_at":"2026-06-02T12:13:03.659821+00:00","sec_items":["2.02","4.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"AZEK restates FY2021-2023 due to inventory fraud; preliminary Q2 beats, raises FY2024 outlook","bullets":["Former employee misstated inventory; income overstated $26-29M aggregate across FY2021-2023 and prior; financials no longer reliable.","Preliminary Q2 FY2024 net sales $418.4M (+11% YoY); residential segment $402.5M (+18% YoY).","YTD FY2024 net income $74-75M, adjusted EBITDA $167-169M (margin ~25.3-25.6%).","Audit Committee concluded restatement; no management involvement; material weaknesses expected."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-021666","json":"https://secwatch.observer/filing/0001628280-24-021666.json","markdown":"https://secwatch.observer/filing/0001628280-24-021666.md","text":"https://secwatch.observer/filing/0001628280-24-021666.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782754/000162828024021666/0001628280-24-021666-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782754/000162828024021666/azek-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T12:13:03.659821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ec1165ba337fd044e6801a0974972cd00536191","claim":"AZEK Co Inc. reported that prior financial statements should not be relied upon.","evidence_excerpt":"the Audit Committee concluded that the consolidated financial statements for the Affected Periods should no longer be relied upon due to the net overstatements described above.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782754/000162828024021666/0001628280-24-021666-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"non reliance"},{"label":"Auditor","value":"PricewaterhouseCoopers LLP"}]},{"claim_id":"cdbc7dfad9f89a5db0bac4134eff25b9408c2cb5","claim":"AZEK Co Inc. reported the six months ended March 31, 2024 results: revenue Consolidated Net Sales of $658.9 million, net income Net income in the range of $74 to $75 million. Guidance raised.","evidence_excerpt":"For the six months ended March 31, 2024, AZEK expects to report results, including: • Consolidated Net Sales of $658.9 million, representing 11% year-over-year growth o Adjusted Net Sales excluding results for Vycom increased 19% year-over-year • Net income in the range of $74 to $75 million • Net profit margin in the range of 11.2% to 11.4% • Adjusted EBITDA in the range of $167 to $169 million • Adjusted EBITDA margin in the range of 25.3% to 25.6%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782754/000162828024021666/0001628280-24-021666-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the six months ended March 31, 2024"},{"label":"Revenue","value":"Consolidated Net Sales of $658.9 million"},{"label":"Net income","value":"Net income in the range of $74 to $75 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"preliminary results"}]},{"claim_id":"f4ee01727b779be9bfaf8f1cac984af08697f59c","claim":"AZEK Co Inc. reported the three months ended March 31, 2024 results: revenue Consolidated Net Sales of $418.4 million. Guidance raised.","evidence_excerpt":"Growth and Material Conversion PRELIMINARY FINANCIAL RESULTS For the three months ended March 31, 2024, AZEK expects to report results, including: • Consolidated Net Sales of $418.4 million, representing 11% year-over-year growth o Adjusted Net Sales excluding results for Vycom increased 17% year-over-year • Residential Segment Net Sales of $402.5 million,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782754/000162828024021666/0001628280-24-021666-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2024"},{"label":"Revenue","value":"Consolidated Net Sales of $418.4 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"preliminary results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}